JensCare-B(09877): JensRoboSiasun Robot & Automation assisted TTVR system completes the first clinical study in humans.

date
08:27 30/03/2026
avatar
GMT Eight
Jianshi Technology-B (09877) announced that the company has successfully completed the first clinical study of the iJensRobo robot-assisted transcatheter tricuspid valve replacement (TTVR) system.
JENSCARE-B (09877) Announcement: Our company has successfully completed the first clinical study using the iJensRoboSiasun Robot&Automation assisted transcatheter tricuspid valve replacement (TTVR) system. Recently, our company completed the first patient clinical study using the iJensRoboSiasun Robot&Automation assisted TTVR system in Hong Kong. The surgery utilized our iJensRoboSiasun Robot&Automation assisted TTVR system to successfully implant the LuX-Valve Plus valve in a patient with severe tricuspid valve regurgitation. Post-surgery ultrasound showed complete disappearance of tricuspid regurgitation, no perivalvular leak, and good stability of the LuX-Valve Plus artificial valve. This system is an innovative Siasun Robot&Automation assisted intervention platform of our company, aiming to provide more precise, stable, and controllable support for TTVR surgery. The iJensRoboSiasun Robot&Automation assisted TTVR system combines high-precision motion control, active safety restraint mechanisms, and intelligent navigation technology to achieve stable and precise instrument manipulation, supporting the safety and reliability of critical operational steps. Compared to traditional manual operation methods, the iJensRoboSiasun Robot&Automation assisted TTVR system helps to reduce potential impacts caused by minor hand tremors, differences in operating range, and spatial positioning deviations. By providing structured guidance for critical operational steps, it enhances the stability and consistency of operations to some extent. At the same time, the system, combined with real-time control and safety limiting mechanisms, helps to reduce risks such as instrument drift, misoperations, and unstable operation paths during complex operation processes, and reduces reliance on the operator's personal experience to some extent. In terms of system architecture, this platform adopts a master-slave control design to reduce the operator's radiation exposure during surgery and improve occupational health risks. Additionally, the system also integrates remote operation functions, with potential support for cross-regional surgical collaboration and remote training.